alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



EXHIBIT 12 Republic Bancorp Inc.
Calculations of Ratios of Earnings to Combined Fixed Charges Three Months Ended(in thousands)
    
    March2004
    
    2003Including Interest on Deposits:Fixed charges:Total interest expense
    
    $
    31,940
    
    
    $
    31,225Interest portion of rent expense
    
    
    194
    
    
    
    196Fixed charges including interest on deposits
    
    $
    32,134
    
    
    $
    31,421Earnings:Net income
    
    $
    16,299
    
    
    $
    15,153Income taxes
    
    
    6,872
    
    
    
    6,851Fixed charges, as above
    
    
    32,134
    
    
    
    31,421Earnings for purposes of calculation
    
    $
    55,305
    
    
    $
    53,425Ratio of earnings to combined fixed charges including
interest on deposits
    
    
    1.72x
    
    
    
    1.70xExcluding Interest on Deposits:Fixed charges:Total interest expense excluding interest on deposits
    
    $
    18,903
    
    
    $
    15,731Interest portion of rent expense
    
    
    194
    
    
    
    196Fixed charges excluding interest on deposits
    
    $
    19,097
    
    
    $
    15,927Earnings:Net income
    
    $
    16,299
    
    
    $
    15,153Income taxes
    
    
    6,872
    
    
    
    6,851Fixed charges, as above
    
    
    19,097
    
    
    
    15,927Earnings for purposes of calculation
    
    $
    42,268
    
    
    $
    37,931Ratio of earnings to combined fixed charges excluding
interest on deposits
    
    
    2.21x
    
    
    
    2.38x
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

Moore Freight Services, Inc., Charles

“ Chip ” Strader, and XMEX Trasports,

L.L.C.,

,

Appellant s

,

v.

Lorena Munoz, Ind. and on Behalf of the

Est. of Lorenzo Munoz, and as N/F of CM,

a Minor Child, Leslie Munoz, Virginia

Munoz, Jessica Lopez, as N/F of AF and

JL, Minor Children and heirs to the Est. of

Roger Franceware, Dec., Rosa

Franc eware, Ind.,

Appellee s

. §

§

§

§

§

§

§

§

§

§ No. 08

- 1 4

- 00254

- C V

Appeal from the

168 th District Court

of El Paso C ounty, Texas

(TC# 2010

- 4169 )

§

O R D E R

The Court GRANTS the Appellee Jessica Lopez third motion for extension of time

within which to file the brief until December 29 , 201 5

. NO FURTHER MOTIONS FOR

EXTENSION OF TIME TO F ILE THE APPELLEE JESSICA LOPEZ BR IEF WILL BE

CONSIDERED BY THIS COURT.

It is further ORDERED that the Hon. Langdon “ Trey ” Smith

, the attorney for Appellee

Jessica Lopez , pre pare the brief and forward the same to this Court on or before December 29

, 201 5

. IT IS SO ORDERED this 30 th day of November , 20 1 5

.

PER CURIAM

Before McClure, C.J., Rodriguez, and Hughes, JJ.

(Hughes, J., not participating)
Filed: November 5, 1998

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-1204

(CR-96-66)

In Re: MICHAEL ANTONIO ADDISON,

Petitioner.

ORDER

The court amends its opinion filed May 1, 1998, as follows:

On page 2, first full paragraph, line 4 -- the words “pled

guilty to” are corrected to read “was convicted of.”

On page 2, second full paragraph, line 1 -- the words “guilty

plea” are corrected to read “convictions.”

For the Court - By Direction

/s/ Patricia S. Connor

Clerk
2

UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 98-1204

In Re: MICHAEL ANTONIO ADDISON,

Petitioner.

On Petition for Writ of Mandamus.

Submitted: April 16, 1998 Decided: May 1, 1998

Before WILKINS and HAMILTON, Circuit Judges, and PHILLIPS, Senior

Circuit Judge.

Petition denied by unpublished per curiam opinion.

Michael Antonio Addison, Petitioner Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
3

PER CURIAM:

Michael Antonio Addison has filed a petition for a writ of

mandamus from this court seeking an order staying the South Carolina state court from proceeding against him in a criminal case.

Subsequent to the filing of this petition, Addison was convicted of

the criminal charges and is now in state custody serving his sentence. Addison has now filed a motion for release, alleging that he

is being held against his will and denied legal materials.

Because Addison's convictions rendered his petition moot, we

deny his mandamus petition and his motion for release. To the

extent Addison's motion for release can be construed as another

mandamus petition challenging the validity of his conviction, we

deny this petition, because Addison has not shown that he has "no

other adequate means to attain the relief he desires" or that his

entitlement to such relief is "clear and indisputable." See Allied

Chem. Corp. v. Daiflon, Inc., 449 U.S. 33, 35 (1980). We also deny

Appellant's motion for an injunction. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid

the decisional process.

PETITION DENIED
<PAGE>
 
                                  Exhibit 21
                        Subsidiaries of the Registrant



   Subsidiaries of The Guarantee Life Companies Inc. as of December 31, 1997
   -------------------------------------------------------------------------

 .  Guarantee Life Insurance Company, a Nebraska stock insurance company

 .  Guarantee Protective Life Company, a Nebraska stock insurance company 

 .  PFG, Inc., a Pennsylvania corporation (of which The Guarantee Life Companies
   Inc. owns 75% of the voting stock and Guarantee Life Insurance Company owns
   25% of the voting stock)

     Subsidiaries of PFG, Inc.: 

         Philadelphia Financial Group, Inc., a Delaware corporation; 
         PFG Distribution Co., a Delaware corporation; and 
         AGL Life Assurance Company, a Pennsylvania corporation
-84 -82 -80 -78 -76 -74 -72

36 38 40 

### ★
▲ ▲ ▲ ▲



### ★ ▲ ▲ ▲ ▲ 500 1000 1500 500 18 12 06 00 08/03 

### NOAA HYSPLIT MODEL 

## Backward trajectory ending at 2300 UTC 03 Aug 07

EDAS Meteorological DataSource★at 39.41 N 76.30 WMeters AGL
<PAGE>   1
                                                                   Exhibit 23(b)


INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this Prospectus Supplement dated
may 12, 1999 to the Registration Statement of Aristar, Inc. on Form S-3, as
supplemented by the Prospectus dated June 23, 1997, of our report dated January
19, 1999, appearing in the Annual Report on Form 10-K of Aristar, Inc. for the
year ended December 31, 1998 and to the reference to us under the heading
"Experts" in the Prospectus Supplement, which is part of the Registration
Statement.


/s/ Deloitte & Touche

Deloitte & Touche

May 12, 1999
Tampa, Florida
[J-77-2020]

IN THE SUPREME COURT OF PENNSYLVANIA

EASTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Appellee

v.

ANDREW LINEMAN,

Appellant

:

:

:

:

:

:

:

:

:

:

:

No. 4 EAP 2020

Appeal from the Judgment of Superior 

Court entered on 9/16/19 at No. 1326 EDA 

2018 affirming the judgment of sentence 

entered on 3/28/18 in the Court of 

Common Pleas, Philadelphia County, 

Criminal Division at No. CP-51-CR0004774-2017

ORDER

PER CURIAM DECIDED: August 7, 2020

AND NOW, this 7th day of August, 2020, the order of the Superior Court is 

REVERSED based on Commonwealth v. Torres, 766 A.2d 342, 345 (Pa. 2001) 

(explaining that a fact-finder’s mere disbelief of the defendant’s testimony going forward 

with the evidence relative to a justification defense is “no substitute for the proof the 

Commonwealth was required to provide to disprove the self-defense claim”).
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF FREESHOP AS OF DECEMBER 31, 1997 AND 1998 AND FOR THE
YEARS ENDED JUNE 30, 1996 AND 1997, THE SIX MONTHS ENDED DECEMBER 31, 1997 AND
THE YEAR ENDED DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FORM S-1.

</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       2,892,144
<SECURITIES>                                         0
<RECEIVABLES>                                  381,830
<ALLOWANCES>                                    42,651
<INVENTORY>                                          0
<CURRENT-ASSETS>                             3,261,820
<PP&E>                                         598,000
<DEPRECIATION>                                 216,704
<TOTAL-ASSETS>                               3,686,570
<CURRENT-LIABILITIES>                        1,248,056
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     7,816,328
<OTHER-SE>                                 (5,572,541)
<TOTAL-LIABILITY-AND-EQUITY>                 3,686,570
<SALES>                                              0
<TOTAL-REVENUES>                             1,250,940
<CGS>                                                0
<TOTAL-COSTS>                                  216,557
<OTHER-EXPENSES>                             4,111,203
<LOSS-PROVISION>                                56,551
<INTEREST-EXPENSE>                              65,654
<INCOME-PRETAX>                            (3,199,025)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (3,199,025)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,199,025)
<EPS-BASIC>                                     (0.21)
<EPS-DILUTED>                                   (0.21)


</TABLE>
<PAGE>   1
                                                                    EXHIBIT 23.3

              CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

      We consent to the reference to our firm under the caption "Experts" and to
the use of our report dated April 2, 1999, except for Note 5 as to which the
date is April 22, 1999, included in the Proxy Statement of fine.com
International Corp. that is made a part of the Registration Statement (Form S-4)
and Prospectus of ARIS Corporation, for the registration of shares of
its common stock.

                                    ERNST & YOUNG LLP


Seattle, Washington
August 2, 1999
§ 520.1802a Piperazine-carbon disulfide complex suspension. ( a ) *Specifications.* Each fluid ounce of suspension contains 7.5 grams of piperazine-carbon disulfide complex. The piperazine-carbon disulfide complex contains equimolar parts of piperazine and carbon disulfide (1 gram contains 530 mgs of piperazine and 470 mgs of carbon disulfide).
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in horses and ponies* — ( 1 ) *Amount.* Administer 1 fluid ounce per 100 pounds of body weight by stomach tube or dose syringe after withholding feed overnight or for 8 to 10 hours.
( 2 ) *Indications for use.* For removing ascarids (large roundworms, *Parascaris equorum),* bots (*Gastrophilus* spp.), small strongyles, large strongyles (*Strongyles* spp.), and pinworms (*Oxyuris equi*).
( 3 ) *Limitations.* Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[45 FR 52781, Aug. 8, 1980, as amended at 78 FR 28826, May 20, 2014]
I 

118TH CONGRESS 

2D SESSION H. R. 7170 

To amend section 3663A of title 18, United States Code, to clarify that 

restitution includes necessary and reasonable expenses incurred by a 

person who has assumed the victim’s rights. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 31, 2024 

Ms. HAGEMAN (for herself, Mrs. MCBATH, Mr. MORAN, and Mr. JOHNSON

of Georgia) introduced the following bill; which was referred to the Committee on the Judiciary 

A BILL 

To amend section 3663A of title 18, United States Code, 

to clarify that restitution includes necessary and reasonable expenses incurred by a person who has assumed 

the victim’s rights. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Victims’ Voices Out5 side and Inside the Courtroom Effectiveness Act’’ or the 

6 ‘‘Victims’ VOICES Act’’. 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
2 

•HR 7170 IH

1 SEC. 2. RESTITUTION FOR EXPENSES OF PERSONS WHO 

2 HAVE ASSUMED THE VICTIM’S RIGHTS. 

3 Section 3663A(a) of title 18, United States Code, is 

4 amended by adding at the end the following: 

5 ‘‘(4) CLARIFICATION.—In ordering restitution under 

6 this section, a court shall order the defendant to make 

7 restitution to a person who has assumed the victim’s 

8 rights under paragraph (2) to reimburse that person’s 

9 necessary and reasonable— 

10 ‘‘(A) lost income, child care, transportation, and 

11 other expenses incurred during and directly related 

12 to participation in the investigation or prosecution of 

13 the offense or attendance at proceedings related to 

14 the offense; 

15 ‘‘(B) lost income, transportation, and other ex16 penses incurred that are directly related to trans17 porting the victim for necessary medical and related 

18 professional services and devices relating to physical, 

19 psychiatric, and psychological care, including non20 medical care and treatment rendered in accordance 

21 with a method of healing recognized by the law of 

22 the place of treatment; and 

23 ‘‘(C) lost income, transportation, and other ex24 penses incurred that are directly related to transVerDate Sep 11 2014 01:20 Feb 06, 2024 Jkt 049200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H7170.IH H7170

kjohnson on DSK7ZCZBW3PROD with $$_JOB
3 

•HR 7170 IH

1 porting the victim to receive necessary physical and 

2 occupational therapy and rehabilitation.’’. 

Æ 


kjohnson on DSK7ZCZBW3PROD with $$_JOB
§ 522.810 Embutramide, chloroquine, and lidocaine solution. ( a ) *Specifications.* Each milliliter (mL) of solution contains 135 milligrams (mg) embutramide; 45 mg chloroquine phosphate, U.S.P.; and 1.9 mg lidocaine, U.S.P.
( b ) *Sponsor.* See No. 069043 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs* — ( 1 ) *Amount.* One mL per 5 pounds of body weight.
( 2 ) *Indications for use.* For euthanasia.
( 3 ) *Limitations.* Not for use in animals intended for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[70 FR 36337, June 23, 2005, as amended at 78 FR 17597, Mar. 22, 2013; 81 FR 17608, Mar. 30, 2016]
<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

        Date of Report (Date of earliest event reported): JUNE 15, 1999


                               CORIXA CORPORATION
             (Exact name of registrant as specified in its charter)

                                     0-22891
                            (Commission File Number)

        DELAWARE                                          91-1654387
        (State or other jurisdiction of     (I.R.S. Employer Identification No.)
        incorporation)


                         1124 COLUMBIA STREET, SUITE 200
                            SEATTLE, WASHINGTON 98104
             (Address of principal executive offices, with zip code)

                                 (206) 754-5711
              (Registrant's telephone number, including area code)

<PAGE>   2
ITEM 5. OTHER EVENTS.

        On June 16, 1999, Corixa Corporation, a Delaware corporation (the
"Company") announced that on June 15, 1999 it had entered into a multi-year
research collaboration and license agreement with the pharmaceutical division of
Japan Tobacco Inc. Further details regarding this announcement are contained in
the Company's press release dated June 16, 1999 attached as an exhibit hereto
and incorporated by reference herein.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.

        (c)    Exhibits.

               Exhibit 99  Corixa Corporation Press Release dated June 16, 1999.

<PAGE>   3
                                   SIGNATURES


        Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                       CORIXA CORPORATION



Date:  June 29, 1999                   By:  /s/ Michelle Burris
                                          --------------------------------------
                                          Michelle Burris
                                          Vice President and Chief
                                          Financial Officer

<PAGE>   4
                               CORIXA CORPORATION

                                INDEX TO EXHIBITS

<TABLE>
<CAPTION>

    EXHIBIT NUMBER             DESCRIPTION
    --------------             -----------
<S>                  <C>
          99         Press Release dated June 16, 1999
</TABLE>
[No. 20897-1-II.

Division Two.

December 5, 1997.]

#### Anne Stanton, *Respondent,*v. Jay Hewitt, et al., *Appellants.*

Appeal from a judgment of the Superior Court for Pierce County, No. 94-2-00483-8, Sergio Armijo, J., entered June 14, 1996. *Affirmed*by unpublished opinion per Bridgewater, J., concurred in by Houghton, C.J., and Armstrong, J.
#### § 573.400 Ethoxyquin in certain dehydrated forage crops.

Ethoxyquin (1,2-dihydro-6-ethoxy-2,2,4-trimethylquinoline) may be safely used in the dehydrated forage crops listed in paragraph (a) of this section when incorporated therein in accordance with the conditions prescribed in this section:

(a) It may be added to dehydrated forage prepared from:

| Alfalfa | Medicago sativa. |
| --- | --- |
| Barley | Hordeum vulgare. |
| Clovers: | |
| Alsike clover | Trifolium hybridum. |
| Crimson clover | Trifolium incarnatum. |
| Red clover | Trifolium pratense. |
| White clover (including Ladino) | Trifolium repens. |
| White sweetclover | Melilotus alba. |
| Yellow sweetclover | Melilotus officinalis. |
| Coastal Bermudagrass | Cynodon dactylon. |
| Corn | Zea mays. |
| Fescue | Festuca sp. |
| Oats | Avena sativa. |
| Orchardgrass | Dactylis glomerata. |
| Reed canarygrass | Pharlaris arundinacea. |
| Ryegrass (annual and perennial) | Elymus sp. and Lolium perenne. |
| Sorghums | Sorghum vulgare vars, feterita, shallu, kaoliang, broomcorn. |
| Sudan grass | Sorghum vulgare sudanense. |
| Wheat | Triticum aestivum. |

or any mixture of such forage crops, for use only as an animal feed.

(b) Such additive is used only as a chemical preservative for the purpose of retarding oxidative destruction of naturally occurring carotenes and vitamin E in the forage crops.

(c) It is added to the dehydrated forage crops in an oil mixture containing only suitable animal or suitable vegetable oil, prior to grinding and mixing.

(d) The maximum quantity of the additive permitted to be used and to remain in or on the dehydrated forage crop shall not exceed 150 parts per million.

(e) To assure the safe use of the additive, the label of the market package shall contain, in addition to other information required by the act:

(1) The name of the additive as specified in this section.

(2) Directions for the incorporation of the additive in the forage crops, as specified in paragraph (c) of this section, with the directive that only suitable animal or suitable vegetable oils are to be used in the oil mix.

(f) The label of any dehydrated forage crops treated with the additive or the label of an animal-feed supplement containing such treated forage crops, shall, in addition to other information required by the act, bear the following statements:

(1) “Ethoxyquin, a preservative,” or “Ethoxyquin added to retard the oxidative destruction of carotene and vitamin E.”

(2) The statement “For use in animal feed only.”
###### Editorial Note on Part 179

#### Editorial Note:

Nomenclature changes to part 179 appear at 70 FR 72074, Dec. 1, 2005.

#### § 179.39 Ultraviolet radiation for the processing and treatment of food.

Ultraviolet radiation for the processing and treatment of food may be safely used under the following conditions:

(a) The radiation sources consist of low pressure mercury lamps emitting 90 percent of the emission at a wavelength of 253.7 nanometers (2,537 Angstroms).

(b) The ultraviolet radiation is used or intended for use as follows:

| Irradiated food | Limitations | Use |
| --- | --- | --- |
| Food and food products | Without ozone production: high fat-content food irradiated in vacuum or in an inert atmosphere; intensity of radiation, 1 W (of 2,537 A. radiation) per 5 to 10 ft.2 | Surface microorganism control. |
| Potable water | Without ozone production; coefficient of absorption, 0.19 per cm or less; flow rate, 100 gal/h per watt of 2,537 A. radiation; water depth, 1 cm or less; lamp-operating temperature, 36 to 46 °C. | Sterilization of water used in food production. |
| Juice products | Turbulent flow through tubes with a minimum Reynolds number of 2,200. | Reduction of human pathogens and other microorganisms. |

[42 FR 14635, Mar. 15, 1977, as amended at 65 FR 71057, Nov. 29, 2000]
§ 56.107 IRB membership. ( a ) Each IRB shall have at least five members, with varying backgrounds to promote complete and adequate review of research activities commonly conducted by the institution. The IRB shall be sufficiently qualified through the experience and expertise of its members, and the diversity of the members, including consideration of race, gender, cultural backgrounds, and sensitivity to such issues as community attitudes, to promote respect for its advice and counsel in safeguarding the rights and welfare of human subjects. In addition to possessing the professional competence necessary to review the specific research activities, the IRB shall be able to ascertain the acceptability of proposed research in terms of institutional commitments and regulations, applicable law, and standards of professional conduct and practice. * * * The IRB shall therefore include persons knowledgeable in these areas. If an IRB regularly reviews research that involves a vulnerable category of subjects, such as children, prisoners, pregnant women, or handicapped or mentally disabled persons, consideration shall be given to the inclusion of one or more individuals who are knowledgeable about and experienced in working with those subjects.
( b ) Every nondiscriminatory effort will be made to ensure that no IRB consists entirely of men or entirely of women, including the instituton's consideration of qualified persons of both sexes, so long as no selection is made to the IRB on the basis of gender. No IRB may consist entirely of members of one profession.
( c ) Each IRB shall include at least one member whose primary concerns are in the scientific area and at least one member whose primary concerns are in nonscientific areas.
( d ) Each IRB shall include at least one member who is not otherwise affiliated with the institution and who is not part of the immediate family of a person who is affiliated with the institution.
( e ) No IRB may have a member participate in the IRB's initial or continuing review of any project in which the member has a conflicting interest, except to provide information requested by the IRB.
( f ) An IRB may, in its discretion, invite individuals with competence in special areas to assist in the review of complex issues which require expertise beyond or in addition to that available on the IRB. These individuals may not vote with the IRB.
[46 FR 8975, Jan. 27, 1981, as amended at 56 FR 28028, June 18, 1991; 56 FR 29756, June 28, 1991; 78 FR 16401, Mar. 15, 2013]